| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 575.20B | 578.13B | 574.95B | 578.56B | 578.56B | 529.67B |
| Gross Profit | 102.73B | 101.30B | 104.19B | 97.95B | 102.34B | 92.11B |
| EBITDA | 48.75B | 81.27B | 74.00B | 75.96B | 76.41B | 68.36B |
| Net Income | 27.95B | 32.61B | 28.31B | 30.55B | 36.44B | 26.89B |
Balance Sheet | ||||||
| Total Assets | 791.38B | 856.38B | 782.97B | 788.73B | 772.36B | 728.19B |
| Cash, Cash Equivalents and Short-Term Investments | 62.29B | 63.07B | 61.22B | 46.01B | 58.22B | 58.14B |
| Total Debt | 180.43B | 181.76B | 176.85B | 176.23B | 239.65B | 229.09B |
| Total Liabilities | 319.38B | 342.92B | 313.83B | 331.42B | 377.59B | 363.18B |
| Stockholders Equity | 432.49B | 472.56B | 429.28B | 418.56B | 358.12B | 329.71B |
Cash Flow | ||||||
| Free Cash Flow | -16.00M | 13.54B | 11.87B | 17.88B | 877.00M | -35.75B |
| Operating Cash Flow | 10.09B | 66.10B | 53.52B | 50.24B | 27.91B | -16.68B |
| Investing Cash Flow | -10.46B | -48.25B | -15.59B | 13.62B | -23.90B | -14.57B |
| Financing Cash Flow | 7.24B | -18.46B | -22.71B | -76.48B | -4.11B | 19.40B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥183.69B | 6.30 | 6.87% | 5.25% | -6.28% | 29.00% | |
71 Outperform | ¥184.25B | 27.66 | 5.06% | 1.80% | 1.69% | 71.95% | |
69 Neutral | ¥765.20B | 7.95 | 10.78% | 4.68% | -4.64% | -21.94% | |
62 Neutral | ¥384.49B | 8.38 | 6.16% | 2.99% | 0.55% | 20.51% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
50 Neutral | ¥2.96T | 175.42 | -0.26% | 4.53% | 15.73% | -95.40% | |
49 Neutral | ¥982.30B | 16.46 | 2.09% | 4.59% | -6.59% | -23.63% |